Updated analyses report on progression-free survival, minimal residual disease negativity, overall response and overall survival across patient types, regardless of age or cytogenetic risk...

Nu Skin Enterprises (NYSE: NUS), a leader in beauty and wellness, today announced its participation in this week's 76th Annual Scientific Meeting & Showcase of the Society of Cosmetic Chemists in...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the company...

Loc Performance, a leading provider of track systems for military, industrial and agricultural applications, today announced its participation in the John Deere dealer Parts Expo at the George R...

Ichnos presentations include clinical and preclinical data on ISB 1342 (CD38xCD3), ISB 1442 (CD38xCD47) and an oral session on ISB 2001, its first TREAT™ trispecific (BCMAxCD38xCD3) antibody NEW...

Green Hills Software, the worldwide leader in embedded safety and security and a member of RISC-V International, will present at the RISC-V Summit. Green Hills Software will participate in a panel...

Boasting the Fastest OLED Performance of Any UltraGear Models, Company's New 27-inch and 45-inch Monitors Deliver Next-level Gaming Immersion U.S. Pre-Order at LG.com Begins Today Featuring Free...

– Freenome's comprehensive multiomics and multi-feature computational approach provides insights for therapy development and patient efficacy SOUTH SAN FRANCISCO, Calif., Dec. 12, 2022...

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that...

Inobrodib is an oral drug showing good long-term tolerability at the recommended phase 2 dose as monotherapy Objective responses have been observed in heavily pre-treated relapsed / refractory...